Pressroom

See all trending topics »Trending Topics

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator »

Memorial Sloan Kettering Team Makes Key Discovery in Understanding Immunotherapy’s Successes—And Its Failures

A collaborative team of leaders in the field of cancer immunology has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do not.

Wednesday, November 19, 2014
Medicare Says It Will Cover Lung Cancer Scans for Long-Time Smokers

The Centers for Medicare and Medicaid Services made a formal proposal to start covering low-dose CT scans for people who fall into a high-risk category for lung cancer. Epidemiologist Peter B. Bach, Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes and a thought leader on this topic, is available to discuss the importance of the proposal. For more information and to set up an interview, email our media staff at mediastaff@mskcc.org.

Tuesday, November 11, 2014
New Thinking on Overdiagnosis and Treatment of Early Thyroid Cancers

MSK physicians are among the thought leaders calling for restraint in diagnosing and treating tiny thyroid tumors that would, if left alone, likely never progress.

Thursday, November 6, 2014

See all press releases »Press Releases

Pictured: Jedd Wolchok, Alexandra Snyder Charen, and Timothy Chan
Memorial Sloan Kettering Team Makes Key Discovery in Understanding Immunotherapy’s Successes—And Its Failures

A collaborative team of leaders in the field of cancer immunology has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do not.

Wednesday, November 19, 2014
Memorial Sloan Kettering Brings Cancer Care Closer to Home for Hudson Valley Residents

Memorial Sloan Kettering’s suburban presence is expanding with its newest and largest state-of-the-art facility set to welcome patients on October 6 in West Harrison, New York.

Wednesday, October 1, 2014
New Academic-Industry Partnership Creates Online Registry for Patients Tested for Inherited Cancer Risk

The Prospective Registry Of Multi-Plex Testing (PROMPT) - a new online, volunteer registry for individuals who have been tested for inherited mutations in cancer-causing genes - will provide data vital to improving our understanding of newly discovered, cancer-associated genes and allow current and future generations to better interpret and benefit from knowledge of their genomes.

Tuesday, September 23, 2014

See all story starters »Story Starters

Need story ideas? Use our evergreen story suggestions to generate new content or complement something you're already working on.

See all blog posts »On Our Blog

Pictured: Daniel Prince
In the Clinic
Restoring Limb Length Following Bone Cancer Surgery

Memorial Sloan Kettering has taken the lead in applying a limb-lengthening technique in people with bone cancer to restore long gaps in bone after removal of a tumor.

Wednesday, November 26, 2014
Pictured: William Alago
Q&A
At Work: Interventional Radiologist William Alago

Interventional radiologist William Alago discusses minimally invasive procedures, advances in imaging techniques, and the future of his field.

Monday, November 24, 2014
Pictured: Jedd Wolchok, Alexandra Snyder Charen and Timothy Chan
In the Lab
New Findings Clarify How Immunotherapy Works — and Why, In Some People, It Doesn’t

In people with melanoma who respond to the drug ipilimumab, certain mutations make tumors more visible to the immune system.

Thursday, November 20, 2014

MSK News Highlights

Watch highlights including news coverage of recent scientific and clinical developments at Memorial Sloan Kettering, our physicians and scientists in the national spotlight, and our amazing staff and programs.

Watch Video »

See all media coverage »Media Coverage

Cancer: Unpronounceable Drugs, Incomprehensible Prices

Epidemiologist Peter Bach commented on the continued rise in cancer drug prices.

Wednesday, August 13, 2014
Gene Mutation Discovered In Breast Cancer Research

Clinical geneticist Kenneth Offit discussed new findings about a gene called PALB2 that is linked to breast cancer.

Friday, August 8, 2014
Early Stem Cell Transplant Vital in 'Bubble Boy' Disease

Pediatric oncologist Richard O’Reilly discussed a study he led that confirms that transplantation for severe combined immunodeficiency works well in very young children.

Thursday, July 31, 2014

For Journalists

Contact Media Staff

Jeanne D'Agostino
Media Relations Manager
Emily O'Donnell
Senior Communications Associate, Department of Surgery
Courtney Nowak
Senior Media Relations Associate
Caitlin Hool
Senior Media Associate
Andrea Baird
Media Associate

For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.

After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

#1 in Cancer Care

MSK Named #1 by U.S. News

News & World Report named Memorial Sloan Kettering the top hospital for cancer care in the nation. We're honored, and patient care will always be our top priority.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

Subscribe to Our
E-Newsletter

Our e-mail newsletter for journalists offers the latest advances in cancer research and treatment, including story ideas, institutional milestones and plans, and newsworthy staff accomplishments.

Sign Up

Read recent issues »